Free Trial

Pfizer (PFE) News Today

Pfizer logo
$21.89 +0.30 (+1.38%)
Closing price 04/11/2025 03:59 PM Eastern
Extended Trading
$21.90 +0.01 (+0.03%)
As of 04/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Validea Detailed Fundamental Analysis - PFE
Pfizer Inc. stock logo
Kennedy Capital Management LLC Has $5.49 Million Stake in Pfizer Inc. (NYSE:PFE)
Kennedy Capital Management LLC lifted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 24.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 206,886 shares of the biopharmaceutical company's stock af
Pfizer Inc. stock logo
Bessemer Group Inc. Sells 21,371 Shares of Pfizer Inc. (NYSE:PFE)
Bessemer Group Inc. decreased its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 15.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 119,250 shares of the biopharmaceutical company's stock af
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by Fmr LLC
Fmr LLC lessened its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 25.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,756,020 shares of the biopharmaceutical company's stock after selling 3,722,
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Pfizer Inc. (NYSE:PFE - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seventeen ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating, five have iss
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Trading Down 1% - Here's Why
Pfizer (NYSE:PFE) Trading Down 1% - Here's Why
Pfizer Inc. stock logo
121,959 Shares in Pfizer Inc. (NYSE:PFE) Bought by Inlight Wealth Management LLC
Inlight Wealth Management LLC bought a new position in Pfizer Inc. (NYSE:PFE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 121,959 shares of the biopharmaceutical company's stock, valued at appr
Pfizer Inc. stock logo
Quinn Opportunity Partners LLC Purchases 104,818 Shares of Pfizer Inc. (NYSE:PFE)
Quinn Opportunity Partners LLC lifted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 23.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 557,728 shares of the biopharmaceutical company
Pfizer Inc. stock logo
Heritage Trust Co Takes Position in Pfizer Inc. (NYSE:PFE)
Heritage Trust Co bought a new position in shares of Pfizer Inc. (NYSE:PFE - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 85,228 shares of the biopharmaceutical company's stock, va
Pfizer Inc. stock logo
Oak Associates Ltd. OH Lowers Holdings in Pfizer Inc. (NYSE:PFE)
Oak Associates Ltd. OH reduced its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 15.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 400,700 shares of the biopharmaceutical company's stock
Pfizer Inc. stock logo
Jaffetilchin Investment Partners LLC Raises Holdings in Pfizer Inc. (NYSE:PFE)
Jaffetilchin Investment Partners LLC lifted its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 217.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,764 shares of th
Pfizer Inc. stock logo
Dymon Asia Capital Singapore PTE. LTD. Sells 18,400 Shares of Pfizer Inc. (NYSE:PFE)
Dymon Asia Capital Singapore PTE. LTD. lessened its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 36.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 31,600 shares of the biopharmaceutical company's stock af
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by Colonial Trust Advisors
Colonial Trust Advisors reduced its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 63.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,923 shares of the biopharmaceutical company's stock aft
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Bought by F M Investments LLC
F M Investments LLC lifted its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 15.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,051 shares of the biopharmaceutical company's stock afte
Pfizer Inc. stock logo
CenterBook Partners LP Lowers Position in Pfizer Inc. (NYSE:PFE)
CenterBook Partners LP decreased its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 79.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 61,997 shares of the biopharmaceutical company's stock after selling 245,797 shares during the period.
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Trading Down 3.9% - Time to Sell?
Pfizer (NYSE:PFE) Trading Down 3.9% - Here's What Happened
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Purchased by Summit Financial Wealth Advisors LLC
Summit Financial Wealth Advisors LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 36.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 107,012 shares of the biopharmaceutical comp
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by First Foundation Advisors
First Foundation Advisors lessened its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 6.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 189,024 shares of the biopharmaceutical company's stock after selling 13,913 shares during the period. First
Pfizer Inc. stock logo
Treasurer of the State of North Carolina Boosts Position in Pfizer Inc. (NYSE:PFE)
Treasurer of the State of North Carolina increased its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 1.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,849,342 shares of the biopharmaceutical
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by Legacy Financial Advisors Inc.
Legacy Financial Advisors Inc. cut its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 22.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 40,436 shares of the biopharmaceutical company's stock after selling 11,757 sh
Pfizer Inc. stock logo
Neuberger Berman Group LLC Cuts Stock Position in Pfizer Inc. (NYSE:PFE)
Neuberger Berman Group LLC trimmed its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 64.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,945,893 shares of the biopharmaceutical company's s
Pfizer Inc. stock logo
LSV Asset Management Acquires 807,215 Shares of Pfizer Inc. (NYSE:PFE)
LSV Asset Management raised its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,752,492 shares of the biopharmaceutical company's stock a
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Sold by Scotia Capital Inc.
Scotia Capital Inc. lessened its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 29.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 794,246 shares of the biopharmaceutical company's stock after selling 328,203 shares durin
Pfizer Inc. stock logo
DRW Securities LLC Acquires Shares of 33,096 Pfizer Inc. (NYSE:PFE)
DRW Securities LLC purchased a new position in shares of Pfizer Inc. (NYSE:PFE - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 33,096 shares of the biopharmaceutical company's stock, valued at approximately $877,000. Several oth
Pfizer Inc. stock logo
Martingale Asset Management L P Acquires 102,521 Shares of Pfizer Inc. (NYSE:PFE)
Martingale Asset Management L P lifted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 416.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 127,129 shares of the biopharmaceutical company's stock
Pfizer (NYSE:PFE) Shares Down 2.7% Following Analyst Downgrade
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Trading Down 2.7% on Analyst Downgrade
Pfizer (NYSE:PFE) Shares Down 2.7% on Analyst Downgrade
Pfizer Inc. stock logo
Estabrook Capital Management Sells 64,456 Shares of Pfizer Inc. (NYSE:PFE)
Estabrook Capital Management decreased its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 17.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 296,030 shares of the biopharmaceutical company's stock after selling 64,456 shares during the
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Purchased by APG Asset Management US Inc.
APG Asset Management US Inc. lifted its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 249.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 117,103 shares of the biopharmaceutical company's stock after buy
Pfizer Inc. stock logo
ELCO Management Co. LLC Sells 13,321 Shares of Pfizer Inc. (NYSE:PFE)
ELCO Management Co. LLC trimmed its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 34.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,376 shares of the biopharmaceutical company's stock after selling 13,3
Pfizer Inc. stock logo
Advisory Services Network LLC Acquires 11,502 Shares of Pfizer Inc. (NYSE:PFE)
Advisory Services Network LLC lifted its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 3.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 339,805 shares of the biopharmaceutical company's stock after purchasi
Pfizer Inc. stock logo
Greenland Capital Management LP Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE)
Greenland Capital Management LP cut its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 53.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,087 shares of the biopharmaceutical company's stock after selling 14,913 shares during the
Pfizer Inc. stock logo
Pfizer Inc. (NYSE:PFE) Shares Bought by FIL Ltd
FIL Ltd boosted its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 28.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,788,512 shares of the biopharmaceutical company's stock after purcha
Pfizer sells San Diego campus for $255M
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Price Target Cut to $24.00 by Analysts at UBS Group
UBS Group dropped their price target on Pfizer from $28.00 to $24.00 and set a "neutral" rating for the company in a research note on Tuesday.
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Stock Price Down 1.5% - What's Next?
Pfizer (NYSE:PFE) Shares Down 1.5% - Should You Sell?
Pfizer Inc. stock logo
Pfizer's (PFE) "Neutral" Rating Reaffirmed at The Goldman Sachs Group
The Goldman Sachs Group reiterated a "neutral" rating and set a $25.00 price objective (down from $32.00) on shares of Pfizer in a report on Tuesday.
Remove Ads
Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

PFE Media Mentions By Week

PFE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PFE
News Sentiment

0.78

0.95

Average
Medical
News Sentiment

PFE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PFE Articles
This Week

97

54

PFE Articles
Average Week

Remove Ads
Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:PFE) was last updated on 4/13/2025 by MarketBeat.com Staff
From Our Partners